pcMSC Modulates Immune Dysregulation in Patients With COVID-19-Induced Refractory Acute Lung Injury

Medicine and Dentistry

• 6 Aminonicotinamide 20%
• Acute Lung Injury 100%
• Acute Respiratory Distress Syndrome 40%
• Adaptive Immunity 20%
• Adverse Event 20%
• B Cell 80%
• C Reactive Protein 20%
• COVID-19 100%
• Cytokine 40%
• Dendritic Cell 20%
• Ferritin 20%
• Flow Cytometry 20%
• Immune Dysregulation 100%
• Immune Response 20%
• Immunocompetent Cell 20%
• Immunosuppressive Treatment 20%
• Infection 20%
• Innate Immunity 20%
• Interleukin 13 20%
• Interleukin-1 20%
• Interleukin-6 20%
• Intravenous Drug Administration 20%
• Lactate Dehydrogenase 20%
• Lymphocytopenia 20%
• Memory T Cell 20%
• Mesenchymal Stem Cell 20%
• Monocyte 40%
• Mortality Rate 20%
• Placenta 20%
• Plasmablast 40%
• Stem Cell Therapy 40%
• T Cell 20%
• T-Helper Cell 40%

Immunology and Microbiology

• Adaptive Immune System 20%
• B Cell 80%
• Blood Plasma 40%
• C-Reactive Protein 20%
• CD14 20%
• CD16 40%
• CD19 60%
• CD4 40%
• COVID-19 100%
• Cytokine 40%
• Dendritic Cell 20%
• Ferritin Blood Level 20%
• Immune Dysregulation 100%
• Immune Response 20%
• Immunocompetent Cell 20%
• Immunosuppressive Therapy 20%
• Innate Immune System 20%
• Interleukin 13 20%
• Interleukin-1 20%
• Interleukin-6 20%
• Lymphocytopenia 20%
• Memory T Cell 20%
• Mesenchymal Stem Cell 20%
• Monocyte 40%
• Mortality Rate 20%
• Placenta 20%
• Plasmablast 40%
• Regulatory T Cell 40%
• Stem Cell Transplantation 40%
• T Cell 20%
• T-Helper Cell 40%

Pharmacology, Toxicology and Pharmaceutical Science

• 6 Aminonicotinamide 20%
• Acute Lung Injury 100%
• Adult Respiratory Distress Syndrome 40%
• Adverse Event 20%
• C Reactive Protein 20%
• Coronavirinae 100%
• Cytokine 40%
• Disease 100%
• Ferritin 20%
• Flow Cytometry 20%
• Immune Dysregulation 100%
• Immunosuppressive Agent 20%
• Infection 20%
• Interleukin 13 20%
• Lactate Dehydrogenase 20%
• Lymphocytopenia 20%
• Mortality Rate 20%